Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study

Instituto de Salud Carlos III, Madrid, SpainCM22/00217
Source: Diabetes Care - Category: Endocrinology Source Type: research